Structure-Based Discovery of TRAF-STOPS: Small Molecule Inhibitors of the CD40-TRAF6 Interaction to block Inflammatory Pathways in Atherosclerosis and other Immune-Modulated Pathologies
that between CD40 protein and its ligand CD40L. For CD40 to elicit intracellular signalling, it needs to recruit adaptor proteins called tumour necrosis factor receptor-associated factors (TRAFs). Interactions…

